Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Rev. bras. ortop ; 57(2): 207-213, Mar.-Apr. 2022. graf
Article in English | LILACS | ID: biblio-1387995

ABSTRACT

Abstract Peripheral nerve damage is an important cause of seeking medical attention. It occurs when the continuity of structures is interrupted and the propagation of nervous impulses is blocked, affecting the functional capacity of individuals. To assess the effects of the immunosuppressants tacrolimus and cyclosporine on the regeneration of peripheral nerves, a systematic review of the literature was carried out. The articles included were published until September 2018 and proposed to evaluate the effects of the immunosuppressants tacrolimus and cyclosporine on nerve regeneration and neuroprotection, available in the MEDLINE, EMBASE, Cochrane Library, Web of Science, Oxford Pain Relief Database, and LILACS databases. The research analysed a total of 56 articles, of which 22 were included in the meta-analysis. Statistical analysis suggests the protective effect of tacrolimus in the regeneration of the number of myelinated axons (95% confidence interval [CI]: 0.93-2.39; p< 0.01); however, such effect was not observed in relation to cyclosporine (95%CI: - 0.38-1.18; p» 0.08) It also suggests that there is a significant relationship between the use of tacrolimus and myelin thickness (95%CI» 2.00-5.71; p< 0. 01). The use of immunosuppressants in the regeneration of peripheral nerve damage promotes an increase in the number of myelinated axons in general, regardless of the administered dose. In addition, it ensures greater myelin thickness, muscle weight and recovery of the sciatic functional index. However, heterogeneity was high in most analyses performed.


Resumo As lesões nervosas periféricas são uma causa importante de busca por atendimento médico. Elas ocorrem quando há a interrupção da continuidade das estruturas e do bloqueio da propagação dos impulsos nervosos, afetando a capacidade funcional dos indivíduos. Para avaliar os efeitos dos imunossupressores tacrolimus e ciclosporina na regeneração de nervos periféricos, foi realizada uma revisão sistemática da literatura. Foram incluídos artigos publicados até setembro de 2018, que se propunham avaliar os efeitos dos imunossupressores tacrolimus e ciclosporina na regeneração nervosa e neuroproteção, disponíveis nas bases de dados MEDLINE, EMBASE, Cochrane Library, Web of Science, Oxford Pain Relief Database e LILACS. A pesquisa analisou um total de 56 artigos, dos quais 22 foram para metanálise. A análise estatística sugere o efeito protetor do tacrolimus na regeneração do número de axônios mielinizados (intervalo de confiança [IC] 95%: 0,93-2,39; p< 0,01); todavia tal efeito não foi observado em relação à ciclosporina (IC95%: - 0,38-1,18; p» 0,08). Ela também sugere haver uma relação significativa entre o uso do tacrolimus e a espessura da mielina (IC95%: 2,00-5,71; p< 0,01). O uso de imunossupressores na regeneração de lesão nervosa periférica promove um aumento no número de axônios mielinizados de forma geral, independentemente da dose administrada. Além disso, garante uma maior espessura da mielina, um maior peso muscular e restabelecimento do índice da função do nervo ciático. Todavia, a heterogeneidade foi alta na maioria das análises realizadas.


Subject(s)
Peripheral Nerves/pathology , Tacrolimus/therapeutic use , Cyclosporine/therapeutic use , Immunosuppressive Agents/therapeutic use , Nerve Regeneration/drug effects
2.
Int. j. cardiovasc. sci. (Impr.) ; 34(5,supl.1): 121-127, Nov. 2021. tab, graf
Article in English | LILACS | ID: biblio-1346340

ABSTRACT

Abstract The association between periodontitis and myocardial infarction remains unclear in the literature. Few studies have addressed periodontitis exposure as a predisposing factor for the development of myocardial infarction. Therefore, the present systematic review aims to analyze the association between periodontitis and myocardial infarction. This meta-analysis systematically searched MEDLINE, EMBASE, The Cochrane Controlled Trials Register, SCIELO, LILACS, CINAHL, Scopus, Web of Science and grey literature for studies estimating the association between periodontitis and myocardial infarction. Quality of evidence was assessed for all studies. The meta-analysis was conducted using random-effects models. Four of the six studies selected were included in the meta-analysis, including 1,035,703 subjects. The association between periodontitis and myocardial infarction was: RR: 5.99 (95% CI: 1.17-30.68), but with high heterogeneity (I2 = 100%; p <0.01). The results including only the highest quality articles, was lower: RR: 2.62 (95% CI: 1.47-4.70 3.83), but with lower heterogeneity (I2 = 85.5%; p < 0.01).The present systematic review with meta-analysis showed an association between periodontitis and acute myocardial infarction, but with a high level of heterogeneity.


Subject(s)
Humans , Periodontitis/complications , Myocardial Infarction/complications , Pulpitis/complications , Atherosclerosis/complications , Lipoproteins/analysis , Myocardial Infarction/etiology , Myocardial Infarction/mortality
3.
Acta méd. (Porto Alegre) ; 39(1): 101-107, 2018.
Article in Portuguese | LILACS | ID: biblio-910383

ABSTRACT

Objetivos: A úlcera do pé diabético é uma complicação comum do Diabetes Mellitus associada a altos custos e longos prazos de tratamento. Sendo assim, é fundamental conhecer terapias adjuvantes que podem melhorar os desfechos desses pacientes. Métodos: Foi realizada uma busca na base MEDLINE sobre terapias clínicas adjuvantes para úlceras do pé diabético. Resultados: Após a seleção de acordo com os critérios de inclusão e exclusão e excluindo artigos duplicados, cinco artigos foram selecionados. Conclusões: A terapia padrão deve continuar sendo utilizada, mas a incorporação de outras opções clínicas de manejo deve ser considerada na prática clínica.


Aims: Diabetic foot ulcer (DFU) is a common complication of Diabetes Mellitus associated with high costs and long treatments. Therefore, it is essential to know clinical adjuvant therapies that can improve the outcomes of these patients. Methods: We searched MEDLINE for articles on adjuvant therapies for DFU. Results: After scanning for the inclusion and exclusion criteria and excluding duplicates, five articles were selected Conclusion: Although the standard of care should still be used, the incorporation of other clinical management options must be considered in clinical practice.


Subject(s)
Ulcer , Diabetic Foot/therapy , Diabetes Mellitus, Type 2/complications
SELECTION OF CITATIONS
SEARCH DETAIL